Literature DB >> 11111833

Modified 5-HT3A receptor function by co-expression of alternatively spliced human 5-HT3A receptor isoforms.

M Brüss1, M Barann, M Hayer-Zillgen, T Eucker, M Göthert, H Bönisch.   

Abstract

Serotonin (5-HT) exerts fast excitatory responses by activation of 5-HT3 receptors, irrespective of whether they are homomerically composed of 5-HT3A subunits or heteromerically assembled of 5-HT3A and 5-HT3B subunits. Here we describe a short, truncated (h5-HT3AT) and a long (h5-HT3AL) splice variant of the human 5-HT3A (hS-HT3A) receptor subunit. The deduced protein of the short isoform consists of 238 amino acids (aa) with a single transmembrane domain (M1). Compared to the known 5-HT3A receptor, the long isoform contains 32 additional aa in the extracellular loop between M2 and M3. Both splice variants are co-expressed together with the 5-HT3A subunit in the amygdala and hippocampus, whereas in the placenta only the short variant is co-expressed. Both splice variants, when expressed in transfected human embryonic kidney (HEK) 293 cells, are not able to form functional homomeric receptors, but modify 5-HT response at heteromeric h5-HT3A receptors. Co-expression of the short variant considerably decelerates the desensitization of the 5-HT3 receptor; thus, heteromeric assemblies of h5-HT3A and the h5-HT3AT subunit exhibit 5-HT-induced cation fluxes which are much larger than those of homomeric hS-HT3A receptors. In contrast, heteromeric complexes containing the h5-HT3AL subunit display reduced cation fluxes. In conclusion, the splice variants increase the functional diversity of 5-HT3 receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11111833     DOI: 10.1007/s002100000342

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  Differential expression of the 5-HT(3A) and 5-HT(3B) receptor in differentiated NG108-15 cells.

Authors:  Hajime Asano; Akinori Miyamoto; Mariko Nakao; Chiyuki Wakaki; Takuma Iida; Yoshinori Funakami; Tetsuyuki Wada; Seiji Ichida
Journal:  Neurochem Res       Date:  2012-04-26       Impact factor: 3.996

2.  Structural determinants of Ca2+ permeability and conduction in the human 5-hydroxytryptamine type 3A receptor.

Authors:  Matthew R Livesey; Michelle A Cooper; Tarek Z Deeb; Jane E Carland; Janna Kozuska; Tim G Hales; Jeremy J Lambert; John A Peters
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

3.  Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site.

Authors:  M Barann; G Molderings; M Brüss; H Bönisch; B W Urban; M Göthert
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  Characterization of an alternative splice variant of human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3): a possible modulator of nucleotidase activity and purinergic signaling.

Authors:  Patrick A Crawford; Keith J Gaddie; Thomas M Smith; Terence L Kirley
Journal:  Arch Biochem Biophys       Date:  2006-11-10       Impact factor: 4.013

Review 5.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

6.  Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.

Authors:  M Barann; K Schmidt; M Göthert; B W Urban; H Bönisch
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 7.  3B but which 3B and that's just one of the questions: the heterogeneity of human 5-HT3 receptors.

Authors:  Anders A Jensen; Paul A Davies; Hans Bräuner-Osborne; Karen Krzywkowski
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

Review 8.  Does pharmacogenomics account for variability in control of acute chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists?

Authors:  Morgan Trammel; Mary Roederer; Jai Patel; Howard McLeod
Journal:  Curr Oncol Rep       Date:  2013-06       Impact factor: 5.075

9.  The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 10.  Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and their Role in the Modulation of Pain Response in the Central Nervous System.

Authors:  Jose Luis Cortes-Altamirano; Adriana Olmos-Hernandez; Herlinda Bonilla Jaime; Paul Carrillo-Mora; Cindy Bandala; Samuel Reyes-Long; Alfonso Alfaro-Rodríguez
Journal:  Curr Neuropharmacol       Date:  2018-01-30       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.